Timothy Pluard
Advertisement
Articles by Timothy Pluard
15 Updated Expert Consensus Recommendations for Managing Hyperglycemia and Rash in Patients With PIK3CA-Mutated, Hormone Receptor–Positive (HR+), Human Epidermal Growth Factor Receptor 2–Negative (HER2–) Advanced Breast Cancer Treated With Alpelisib
ByEmily J. Gallagher,Heather Moore,Mario E. Lacouture, MD,Susan F. Dent,Azeez Farooki, MD,Marcus D. Goncalves,Claudine Isaacs, MD,Abigail Johnston,Dejan Juric,Zoe Quandt,Laura Spring,Brian Berman,Melanie Decker,Gabriel N. Hortobagyi, MD, FACP,Benjamin H. Kaffenberger,Bernice Y. Kwong,Timothy Pluard,Ruta Rao, MD,Lee Schwartzberg, MD, FACP,Michael S. Broder
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on CancerNetwork
1
Lu 177 Plus Immunotherapy Displays Responses in Prostate Cancer
2
Daratumumab Combo Yields Significantly Higher MRD Negativity in Multiple Myeloma
3
Ceralasertib Combo Misses OS End Point in Advanced NSCLC Trial
4
FDA Grants BTD to T-DXd in HER2+ BC With Residual Invasive Disease Post NAT
5